Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Transfusable Blood to Be Made From ESCs

By LabMedica International staff writers
Posted on 07 Apr 2009
Scientists are attempting to create synthetic blood from embryonic stem cells (ESCs).

Surplus embryos used for in vitro fertilization (IVF) treatments will be screened to find the stem cells that can develop into O-negative blood, which can be transfused into virtually every patient. More...
The stem cells can then be developed into red blood cells, offering potentially an inexhaustible supply of blood for emergency situations. This will be of great significance for the military and emergency units around the world.

In the year 2008 Advanced Cell Technology (Los Angeles, CA, USA) announced that it could make a fresh supply of blood from embryonic stem cells. Scientists in the United Kingdom, Sweden, France, and Australia are also working in the field. A consortium consisting of the NHS Blood and Transplant (Bristol, UK), Scottish National Blood Transfusion Service (Edinburgh, UK), and Wellcome Trust (London, UK) is supporting the project. They believe that the new blood supply should be ready for testing in humans within three years.

Related Links:

Advanced Cell Technology
NHS Blood and Transplant
Scottish National Blood Transfusion Service
Wellcome Trust




Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The simple blood marker can predict which lymphoma patients will benefit most from CAR T-cell therapy (Photo courtesy of Shutterstock)

Routine Blood Test Can Predict Who Benefits Most from CAR T-Cell Therapy

CAR T-cell therapy has transformed treatment for patients with relapsed or treatment-resistant non-Hodgkin lymphoma, but many patients eventually relapse despite an initial response. Clinicians currently... Read more

Pathology

view channel
Image: Determining EG spiked into medicinal syrups: Zoomed-in images of the pads on the strips are shown. The red boxes show where the blue color on the pad could be seen when visually observed (Arman, B.Y., Legge, I., Walsby-Tickle, J. et al. https://doi.org/10.1038/s41598-025-26670-1)

Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.